Raymond James & Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-223,019	Closed	-$198K	–	4147
2022 Q4	$198K	Sell	223,019 -34,300	-13%	-$45.5K	﹤0.01%	3459
2022 Q3	$404K	Buy	257,319 +101,500	+65%	+$230K	﹤0.01%	2991
2022 Q2	$313K	Sell	155,819 -11,006	-7%	-$19K	﹤0.01%	3203
2022 Q1	$389K	Sell	166,825 -12,932	-7%	-$40.3K	﹤0.01%	3234
2021 Q4	$836K	Buy	179,757 +28,000	+18%	+$174K	﹤0.01%	2742
2021 Q3	$1.16M	Buy	151,757 +39,300	+35%	+$333K	﹤0.01%	2482
2021 Q2	$1.09M	Buy	112,457 +26,186	+30%	+$209K	﹤0.01%	2531
2021 Q1	$713K	Sell	86,271 -23,364	-21%	-$247K	﹤0.01%	2747
2020 Q4	$748K	Sell	109,635 -8,185	-7%	-$65.7K	﹤0.01%	2535
2020 Q3	$1.31M	Sell	117,820 -114,009	-49%	-$1.04M	﹤0.01%	2010
2020 Q2	$1.46M	Buy	231,829 +220,579	+1,961%	+$844K	﹤0.01%	1919
2020 Q1	$21K	Buy	+11,250	New	+$32.4K	﹤0.01%	3397
2016 Q2	–	Sell	-16,000	Closed	-$86K	–	3106
2016 Q1	$86K	Buy	+16,000	New	+$93K	﹤0.01%	2740